COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

FILE - The anti-viral drug Paxlovid is displayed in New York, Monday, Aug. 1, 2022. Pfizer received full approval for the COVID-19 medication on Thursday, May 25, 2023, winning the U.S. Food and Drug Administration's full endorsement for a drug that has been the go-to treatment against the virus for more than two years. (AP Photo/Stephanie Nano, File)